Shanghai, China

Songliang Wu

This inventor holds 8 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignees: Shanghai Haiyan Pharmaceutical Technology Co., Ltd., Yangtze River Pharmaceutical Group Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2018-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Songliang Wu. Retrieved from https://idiyas.com/inventor/songliang-wu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

 

Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Shanghai, CN (2018 - 2021)
  • Nanjing, CN (2021 - 2022)

Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Songliang Wu - Innovative Inventor from Shanghai

Introduction: Songliang Wu is a renowned inventor hailing from Shanghai, China, known for his groundbreaking contributions to various technological fields.

Latest Patents: Songliang Wu holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With over two decades of experience in the industry, Songliang Wu has worked with leading research institutions and multinational companies, spearheading projects that have revolutionized the way we approach modern challenges.

Collaborations: Throughout his career, Songliang Wu has collaborated with top universities and tech companies worldwide, fostering a culture of innovation and knowledge-sharing that has led to significant advancements in science and technology.

Conclusion: Songliang Wu's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, inspiring the next generation of innovators to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…